{"data":[{"accessionNo":"0000921895-26-002220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Morgan Adam","reportingCik":null,"personType":"IN","sharesOwned":3363347,"percentOfClass":9.9,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-002220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Velan Capital Investment Management LP","reportingCik":null,"personType":"PN","sharesOwned":3363347,"percentOfClass":9.9,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-002220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Velan Capital Management LLC","reportingCik":null,"personType":"OO","sharesOwned":3363347,"percentOfClass":9.9,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-002220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"VENKATARAMAN BALAJI","reportingCik":null,"personType":"IN","sharesOwned":3363347,"percentOfClass":9.9,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-002220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Velan Capital Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":3037776,"percentOfClass":8.9,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-002220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Velan Capital Holdings LLC","reportingCik":null,"personType":"OO","sharesOwned":3037776,"percentOfClass":8.9,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-002220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Avego Healthcare Capital Holdings, LLC","reportingCik":null,"personType":"OO","sharesOwned":243563,"percentOfClass":0.7,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-002220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Avego Management LLC","reportingCik":null,"personType":"OO","sharesOwned":243563,"percentOfClass":0.7,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-002220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Avego Healthcare Capital, L.P.","reportingCik":null,"personType":"PN","sharesOwned":243563,"percentOfClass":0.7,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-002220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Velan Horizon GP LLC","reportingCik":null,"personType":"OO","sharesOwned":82008,"percentOfClass":0.2,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-002220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Velan Horizon Fund LP","reportingCik":null,"personType":"PN","sharesOwned":82008,"percentOfClass":0.2,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-002220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Kapoor Vishal","reportingCik":null,"personType":"IN","sharesOwned":35013,"percentOfClass":0.1,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-001834","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-07-16","reportingPerson":"Morgan Adam","reportingCik":"0001964335","personType":"IN","sharesOwned":3349547,"percentOfClass":9.88,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-001834","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-07-16","reportingPerson":"Velan Capital Management LLC","reportingCik":"0001964355","personType":"OO","sharesOwned":3349547,"percentOfClass":9.88,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-001834","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-07-16","reportingPerson":"Velan Capital Investment Management LP","reportingCik":"0001848809","personType":"PN","sharesOwned":3349547,"percentOfClass":9.88,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-001834","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-07-16","reportingPerson":"VENKATARAMAN BALAJI","reportingCik":"0001114916","personType":"IN","sharesOwned":3349547,"percentOfClass":9.88,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-001834","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-07-16","reportingPerson":"Velan Capital Master Fund LP","reportingCik":"0001964356","personType":"PN","sharesOwned":3021915,"percentOfClass":8.9,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-001834","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-07-16","reportingPerson":"Velan Capital Holdings LLC","reportingCik":"0001964353","personType":"OO","sharesOwned":3021915,"percentOfClass":8.9,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-001834","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-07-16","reportingPerson":"Avego Management LLC","reportingCik":"0001886177","personType":"OO","sharesOwned":245328,"percentOfClass":0.7,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-001834","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-07-16","reportingPerson":"Avego Healthcare Capital Holdings, LLC","reportingCik":"0001964446","personType":"OO","sharesOwned":245328,"percentOfClass":0.7,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-001834","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-07-16","reportingPerson":"Avego Healthcare Capital, L.P.","reportingCik":"0001822834","personType":"PN","sharesOwned":245328,"percentOfClass":0.7,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-001834","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-07-16","reportingPerson":"Velan Horizon GP LLC","reportingCik":"0002057821","personType":"OO","sharesOwned":82304,"percentOfClass":0.2,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-001834","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-07-16","reportingPerson":"Velan Horizon Fund LP","reportingCik":"0002057740","personType":"PN","sharesOwned":82304,"percentOfClass":0.2,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-26-001834","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-07-16","reportingPerson":"Kapoor Vishal","reportingCik":"0001798946","personType":"IN","sharesOwned":35013,"percentOfClass":0.1,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001104659-26-082738","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":486933,"percentOfClass":1.7,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001104659-26-082738","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":486933,"percentOfClass":1.7,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001104659-26-082738","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":486933,"percentOfClass":1.7,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001104659-26-082738","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":486454,"percentOfClass":1.7,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000895421-26-000171","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock","eventDate":"2026-03-31","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":1333420,"percentOfClass":4.8,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000895421-26-000171","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock","eventDate":"2026-03-31","reportingPerson":"Morgan Stanley Capital Services LLC","reportingCik":null,"personType":"BD,CO","sharesOwned":1294420,"percentOfClass":4.6,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001213900-26-053990","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS, INC.","ticker":"JSPR","cusip":"471871202","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Guy Levy","reportingCik":null,"personType":"IN","sharesOwned":276312,"percentOfClass":1,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001213900-26-053990","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS, INC.","ticker":"JSPR","cusip":"471871202","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Soleus GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":276312,"percentOfClass":1,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001213900-26-053990","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS, INC.","ticker":"JSPR","cusip":"471871202","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Soleus Capital Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":276312,"percentOfClass":1,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001213900-26-053990","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS, INC.","ticker":"JSPR","cusip":"471871202","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Soleus PE GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":157400,"percentOfClass":0.6,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001213900-26-053990","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS, INC.","ticker":"JSPR","cusip":"471871202","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Soleus Private Equity Fund III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":157400,"percentOfClass":0.6,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001213900-26-053990","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS, INC.","ticker":"JSPR","cusip":"471871202","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Soleus Private Equity GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":157400,"percentOfClass":0.6,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000886982-26-000153","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS INC","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"THE GOLDMAN SACHS GROUP, INC.","reportingCik":null,"personType":"HC,CO","sharesOwned":128862,"percentOfClass":0.5,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000886982-26-000153","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS INC","ticker":"JSPR","cusip":"471871202","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"GOLDMAN SACHS & CO. LLC","reportingCik":null,"personType":"BD,OO,IA","sharesOwned":128862,"percentOfClass":0.5,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001213900-26-053990","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS, INC.","ticker":"JSPR","cusip":"471871202","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Soleus Capital, LLC","reportingCik":null,"personType":"OO","sharesOwned":118912,"percentOfClass":0.4,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001213900-26-053990","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS, INC.","ticker":"JSPR","cusip":"471871202","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Soleus Capital Master Fund, L.P.","reportingCik":null,"personType":"FI","sharesOwned":118912,"percentOfClass":0.4,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001213900-26-053990","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS, INC.","ticker":"JSPR","cusip":"471871202","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Soleus Capital Group, LLC","reportingCik":null,"personType":"OO","sharesOwned":118912,"percentOfClass":0.4,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001104659-26-019751","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1629013,"percentOfClass":5.8,"filedAt":"2026-02-25","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001104659-26-019751","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":1629013,"percentOfClass":5.8,"filedAt":"2026-02-25","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001104659-26-019751","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":1624076,"percentOfClass":5.8,"filedAt":"2026-02-25","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001104659-26-019751","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1629013,"percentOfClass":5.8,"filedAt":"2026-02-25","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001493152-26-007366","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Abingworth Bioventures VII LP","reportingCik":"0001688313","personType":"PN","sharesOwned":1088310,"percentOfClass":3.8,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001493152-26-007366","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"The Carlyle Group Inc.","reportingCik":"0001527166","personType":"CO","sharesOwned":1088310,"percentOfClass":3.8,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001493152-26-007366","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Carlyle Holdings I GP Inc.","reportingCik":"0001548626","personType":"CO","sharesOwned":1088310,"percentOfClass":3.8,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001493152-26-007366","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Carlyle Holdings I GP Sub L.L.C.","reportingCik":"0001548627","personType":"OO","sharesOwned":1088310,"percentOfClass":3.8,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001493152-26-007366","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Carlyle Holdings I L.P.","reportingCik":"0001548628","personType":"PN","sharesOwned":1088310,"percentOfClass":3.8,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001493152-26-007366","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"CG Subsidiary Holdings L.L.C.","reportingCik":"0001790577","personType":"OO","sharesOwned":1088310,"percentOfClass":3.8,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001493152-26-007366","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"TC Group, L.L.C.","reportingCik":"0000933790","personType":"OO","sharesOwned":1088310,"percentOfClass":3.8,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001493152-26-007366","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Carlyle Investment Management L.L.C.","reportingCik":"0001354120","personType":"OO","sharesOwned":1088310,"percentOfClass":3.8,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001493152-26-007366","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Carlyle Genesis UK LLC","reportingCik":"0001941860","personType":"OO","sharesOwned":1088310,"percentOfClass":3.8,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001493152-26-007366","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Abingworth LLP","reportingCik":"0001397144","personType":"PN","sharesOwned":1088310,"percentOfClass":3.8,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000886982-26-000077","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS INC","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"THE GOLDMAN SACHS GROUP, INC.","reportingCik":null,"personType":"HC,CO","sharesOwned":1764848,"percentOfClass":6.3,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000886982-26-000077","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS INC","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"GOLDMAN SACHS & CO. LLC","reportingCik":null,"personType":"BD,OO,IA","sharesOwned":1764848,"percentOfClass":6.3,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000895421-26-000039","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock","eventDate":"2025-12-31","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":1969785,"percentOfClass":7,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000895421-26-000039","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock","eventDate":"2025-12-31","reportingPerson":"Morgan Stanley Capital Services LLC","reportingCik":null,"personType":"BD,CO","sharesOwned":1903420,"percentOfClass":6.8,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001636587-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2026-01-23","reportingPerson":"Anders Hove","reportingCik":null,"personType":"IN","sharesOwned":1486492,"percentOfClass":5.3,"filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001636587-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2026-01-23","reportingPerson":"ACORN BIOVENTURES 2, L.P.","reportingCik":null,"personType":"PN","sharesOwned":862166,"percentOfClass":3.1,"filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001636587-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2026-01-23","reportingPerson":"Acorn Capital Advisors GP 2, LLC","reportingCik":null,"personType":"OO","sharesOwned":862166,"percentOfClass":3.1,"filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001636587-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2026-01-23","reportingPerson":"ACORN BIOVENTURES, L.P.","reportingCik":null,"personType":"PN","sharesOwned":624326,"percentOfClass":2.2,"filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001636587-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2026-01-23","reportingPerson":"ACORN CAPITAL ADVISORS GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":624326,"percentOfClass":2.2,"filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001636587-25-000064","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2025-12-01","reportingPerson":"Anders Hove","reportingCik":null,"personType":"IN","sharesOwned":1786492,"percentOfClass":6.4,"filedAt":"2025-12-02","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001636587-25-000064","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2025-12-01","reportingPerson":"ACORN BIOVENTURES 2, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1036166,"percentOfClass":3.7,"filedAt":"2025-12-02","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001636587-25-000064","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2025-12-01","reportingPerson":"Acorn Capital Advisors GP 2, LLC","reportingCik":null,"personType":"OO","sharesOwned":1036166,"percentOfClass":3.7,"filedAt":"2025-12-02","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001636587-25-000064","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2025-12-01","reportingPerson":"ACORN BIOVENTURES, L.P.","reportingCik":null,"personType":"PN","sharesOwned":750326,"percentOfClass":2.7,"filedAt":"2025-12-02","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001636587-25-000064","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2025-12-01","reportingPerson":"ACORN CAPITAL ADVISORS GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":750326,"percentOfClass":2.7,"filedAt":"2025-12-02","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001897612-25-000546","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001788028","issuerName":"JASPER THERAPEUTICS INC","ticker":"JSPR","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":2057612,"percentOfClass":7.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001765710-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001","eventDate":"2025-09-30","reportingPerson":"Mark McDade","reportingCik":null,"personType":"IN","sharesOwned":928964,"percentOfClass":3.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001765710-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001","eventDate":"2025-09-30","reportingPerson":"Qiming U.S. Healthcare Fund II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":928964,"percentOfClass":3.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001765710-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001","eventDate":"2025-09-30","reportingPerson":"Qiming U.S. Healthcare GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":928964,"percentOfClass":3.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0001765710-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001","eventDate":"2025-09-30","reportingPerson":"GARY E RIESCHEL","reportingCik":null,"personType":"IN","sharesOwned":928964,"percentOfClass":3.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000919574-25-006584","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Mark Kingdon","reportingCik":null,"personType":"HC,IN","sharesOwned":1324845,"percentOfClass":4.7,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000919574-25-006584","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Kingdon Capital Management, L.L.C.","reportingCik":null,"personType":"IA","sharesOwned":1324845,"percentOfClass":4.7,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000895421-25-000572","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock","eventDate":"2025-09-30","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":784628,"percentOfClass":2.8,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-25-002600","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-19","reportingPerson":"Velan Capital Investment Management LP","reportingCik":"0001848809","personType":"PN","sharesOwned":2668395,"percentOfClass":9.6,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-25-002600","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-19","reportingPerson":"Morgan Adam","reportingCik":"0001964335","personType":"IN","sharesOwned":2668395,"percentOfClass":9.6,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-25-002600","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-19","reportingPerson":"Velan Capital Management LLC","reportingCik":"0001964355","personType":"OO","sharesOwned":2668395,"percentOfClass":9.6,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-25-002600","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-19","reportingPerson":"VENKATARAMAN BALAJI","reportingCik":"0001114916","personType":"IN","sharesOwned":2668395,"percentOfClass":9.6,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-25-002600","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-19","reportingPerson":"Velan Capital Master Fund LP","reportingCik":"0001964356","personType":"PN","sharesOwned":2381915,"percentOfClass":8.5,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-25-002600","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-19","reportingPerson":"Velan Capital Holdings LLC","reportingCik":"0001964353","personType":"OO","sharesOwned":2381915,"percentOfClass":8.5,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-25-002600","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-19","reportingPerson":"Avego Healthcare Capital Holdings, LLC","reportingCik":"0001964446","personType":"OO","sharesOwned":245328,"percentOfClass":0.9,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-25-002600","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-19","reportingPerson":"Avego Healthcare Capital, L.P.","reportingCik":"0001822834","personType":"PN","sharesOwned":245328,"percentOfClass":0.9,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-25-002600","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-19","reportingPerson":"Avego Management LLC","reportingCik":"0001886177","personType":"OO","sharesOwned":245328,"percentOfClass":0.9,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-25-002600","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-19","reportingPerson":"Kapoor Vishal","reportingCik":"0001798946","personType":"IN","sharesOwned":23867,"percentOfClass":0.1,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-25-002600","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-19","reportingPerson":"Velan Horizon GP LLC","reportingCik":"0002057821","personType":"OO","sharesOwned":41152,"percentOfClass":0.1,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"},{"accessionNo":"0000921895-25-002600","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001788028","issuerName":"Jasper Therapeutics, Inc.","ticker":"JSPR","cusip":null,"securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2025-09-19","reportingPerson":"Velan Horizon Fund LP","reportingCik":"0002057740","personType":"PN","sharesOwned":41152,"percentOfClass":0.1,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/jspr"}],"updatedAt":"2026-10-24T19:03:45.313Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/jspr","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}